Efficacy Of Macular Photocoagulation When Given In The Early Or Late Period After Single Intravitreal Bevacizumab Injection In Terms Of Central Foveal Thickness Change And Visual Acuity Gain

Indian Journal of Applied Basic Medical Sciences
Year: 2021, Volume: 23(A), Issue. (1)
First page: (267) Last page: (279)
Online ISSN: 2249-7935
Print ISSN: 0975-8917
doi: 10.48165/ijabms.2021.23122

Efficacy Of Macular Photocoagulation When Given In The Early Or Late Period After Single Intravitreal Bevacizumab Injection In Terms Of Central Foveal Thickness Change And Visual Acuity Gain
Aaska Sapan Shah1*, Naimish Haribhai Mahaliya2, Sapan Snehalbhai shah3 and Jigar Jitendrabhai Joshi4
1Vitreo-retinalsurgeon, C H Nagri Hospital
23rdyear resident doctor,3Oculoplastysurgeon, 42nd year resident doctor, LG Hospital, Sheth Lallubhai Gordhandas Municipal General Hospital
Corresponding Author: Aaska Sapan Shah, Email:shah7aashi@yahoo.com

Online Published on 02-February-2021

ABSTRACT

AIM: To find out the efficacy of macular photocoagulation when given in the early or late period after single intravitreal bevacizumab injection in terms of central foveal thickness change and visual acuity gain.METHODS:40 patient eyes were studied and they were divided into groups based on sex, age, hba1c levels, severity of disease and treatment received over the period of 6months.RESULT: patients receiving deferred macular photocoagulation after a single intravitreal injection of bevacizumab had better outcomes regarding reduction of central foveal thickness and improvement in visual acuity at the end of 6-month observation period compared to those patients receiving prompt macular photocoagulation.

Keywords

bevacizumab, laser photocoagulation, diabetic retinopathy

[pms-restrict subscription_plans=”10827″]
[/pms-restrict]